Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Hypertension Age: Adult |
Dose: Tablet – 40 mg Frequency: once daily Note: Dosage must be individualized. Blood pressure response is dose-related over the range of 20 to 80 mg. Most of the anti hypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeks. Initial therapy with Telmisartan is not recommended in patients greater than 75 years old or with hepatic impairment. |
|
Indication: Cardiovascular risk reduction Age: Adult |
Dose: Tablet – 80 mg Frequency: once daily Note: It is not known whether doses lower than 80 mg of telmisartan are effective in reducing the risk of cardiovascular morbidity and mortality. When initiating therapy, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: less than 18 years old |
Dose: Form – Not established Note: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Mild to moderate renal impairment |
Dose: Not specified – No initial dosage adjustment is required Note: No initial dosage adjustment is required for patients with mild to moderate renal impairment. |
|
Condition: Severe renal impairment |
Dose: Not specified – Titrate slowly Note: Titrate slowly in patients with severe renal impairment. |
Administration
- Can be taken with or without food
- Take at same time daily
Side Effect
- Upper respiratory tract infection (URTI) (URTI) (7%)
- Back pain (3%)
- Diarrhea (3%)
- Myalgia (3%)
- Sinusitis (3%)
- Chest pain (1%)
- Hypertension (1%)
- Headache (1%)
- Dizziness (1%)
- Pharyngitis (1%)
- ECG
- Anemia
- Angina
- Angioedema
- Bradycardia
- Eczema
- Epistaxis
- Gout
- Hypercholesterolemia
- Hyperkalemia
- Hypoglycemia
- Otitis media
- Rarely angioedema
- rash
- pruritus and urticaria
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Digoxin
|
May increase plasma levels
|
|
Lithium
|
May increase serum levels and toxicity
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe Hepatic Impairment
|
Can cause liver damage
|
|
Biliary Obstructive Disorders
|
Can worsen bile flow problems
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Do not store above 30°C. Protect from light and high humidity. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.